International Isotopes Inc. Announces First Quarter 2009 Financial Results
Revenue Increase 30% to
Revenue for the three-month period ended
Excluding bulk cobalt sales, revenue for the three-month period ended
Three-Month Financial Measure Reconciliation Period ended March 31, 2009 Period ended March 31, 2008 Total Revenues $1,699,670 $1,307,938 Bulk Cobalt Products Revenues $494,661 $0 Total Revenues Excluding Bulk Cobalt Products Revenues $1,205,009 $1,307,938
Revenue from the sale of radiochemical products for the three-month period ending
Gross profit for the three-month period ended
Our net loss for the three-month period ended
International Isotopes Inc. Three Months Ended March 31 2009 2008 Sales of Product $1,699,670 $1,307,938 Gross Profit $868,934 $698,402 Total Operating Expenses $1,440,314 $1,145,507 Operating (Loss) ($571,200) ($447,105) Total Other Income (Expense) $(16,727) ($18,839) Net (Loss) ($587,927) ($465,944) Net (Loss) Per Common Share basic and diluted ($0.00) ($ 0.00) Weighted Av. Share Outstanding basic and diluted 288,802,293 262,570,892
About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients
International Isotopes Inc. Safe Harbor Statement
Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to improving market penetration, capitalizing upon market opportunities, expected future losses, plans to construct a commercial depleted uranium de-conversion facility, future growth opportunities, and the prospect of positive shareholder returns. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.’s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-KSB for the year ending
For More Information, Contact: Steve Laflin, President and CEO (208) 524-5300
SOURCE International Isotopes Inc.